TABLE V.
Treatment | Xenograft LAPC-4 tumor tissue, VEGF mRNA level (fold of control) |
Xenograft LNCaP tumor tissue, VEGF mRNA level (fold of control) |
---|---|---|
Placebo | 1.00 ± 0.12 (5) | 1.00 ± 0.17 (6) |
αE2 2 mg | 1.13 ± 0.20 (4) | 1.34 ± 0.27 (6) |
βE2 2 mg | 1.18 ± 0.09 (4) | 1.07 ± 0.23 (6) |
The data are the mean ± SEM and the number in parenthesis indicates the sample size.